TMCnet News
Research and Markets: Global Diabetic Retinopathy Market 2014-2018DUBLIN --(Business Wire)-- Research and Markets (http://www.researchandmarkets.com/research/q86k3s/global_diabetic) has announced the addition of the "Global Diabetic Retinopathy Market 2014-2018" report to their offering. DR is defined as an eye disorder that damages the blood vessels of the retina. The retina is the light-sensitive inner surface of the eye which acts as a film for the formation of an image. Long-term diabetes affects the retina as a high blood glucose level can deteriorate and damage the tiny blood vessels in the retina. DR is broadly classified into either non-proliferative DR or proliferative retinopathy. Treatment for DR is dependent on the stage of the disease and is directed at trying to slow or stop the progression of the disease. At present, three types of treatment exist for DR: laser surgery, injection of corticosteroids or anti-VEGF drugs into the eye, and vitrectomy. The aalysts forecast the Global DR market will grow at a CAGR of 6.8 percent over the period 2013-2018. Key Topics Covered: 01. Executive Summary 02. List of Abbreviations 03. Scope of the Report 04. Market Research Methodology 05. Introduction 06. Market Landscape 07. Pipeline Snapshot 08. Rate of Incidence and Prevalence 09. Geographical Segmentation 10. Buying Criteria 11. Market Growth Drivers 12. Drivers and their Impact 13. Market Challenges 14. Impact of Drivers and Challenges 15. Market Trends 16. Trends and their Impact 17. Vendor Landscape 18. Key Vendor Analysis 19. Other Reports in this Series Companies Mentioned:
For more information visit http://www.researchandmarkets.com/research/q86k3s/global_diabetic
|